Status:
RECRUITING
Evaluate the Effectiveness of Progestin-Primed Versus GnRH Antagonist Protocols in Vietnamese Women Undergoing In-vitro Fertilization
Lead Sponsor:
Hanoi Medical University
Conditions:
IVF
Eligibility:
FEMALE
20-45 years
Phase:
NA
Brief Summary
This study aims to evaluate the efficacy of the progestin-primed ovary stimulation (PPOS) protocol compared to the standard GnRH antagonist (GnRH\_ant) protocol across successive stages in a controlle...
Detailed Description
Materials and Method This was an open-label, randomized controlled trial conducted at the Assisted Reproduction Center of Tam Anh General Hospital. The study aimed to estimate the efficacy of the int...
Eligibility Criteria
Inclusion
- Women meeting the sample selection criteria are as follows:
- Women age 20 to 45 years old.
- Infertility due to male factors, fallopian tube factors, or unknown causes.
- Undergoing IVF in one COS cycle and intended to apply either GnRH antagonist protocol or PPOS protocol
- Voluntary participation in research.
Exclusion
- Any contraindications to ovarian stimulation and IVF/ICSI treatment
- Hyperprolactinemia or other endocrine diseases.
- Those who took hormone drugs within the past 3 months
- Suffering from systemic diseases such as kidney failure, lupus erythematosus, depression, etc.
- Abnormal structure of the uterine cavity.
- Patients with endometriosis or cancer
- Random-start cycles.
- Oocyte donation cycles
- Perform embryo biopsy.
Key Trial Info
Start Date :
February 14 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06191809
Start Date
February 14 2023
End Date
December 31 2024
Last Update
January 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Univesity of Medicine and Pharmacy at Ho Chi Minh City
Ho Chi Minh City, Vietnam, 700000